No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
TD Cowen Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating
Tyra Biosciences Advances Precision Medicine Pipeline
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $33
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $28
We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth
TYRA BIOSCIENCES, INC. | 10-K: FY2024 Annual Report